Vitamin A deficiency: Not seeing well at night is among the 'first signs' of sight loss
VITAMIN A deficiency is known to impact eyesight. Indeed, if you find yourself struggling to see well at night, it may be the cause. (Source: Daily Express - Health)
Source: Daily Express - Health - May 1, 2022 Category: Consumer Health News Source Type: news
What the Science Says About the Health Benefits of Vitamins and Supplements
From multivitamins and melatonin to fiber and fish oil, Americans who are trying to boost their health and immunity have a plethora of supplements to choose from. An estimated 58% of U.S. adults ages 20 and over take dietary supplements, according to the U.S. Centers for Disease Control and Prevention, and the supplement industry is valued at more than $30 billion a year. Supplement use has been growing rapidly over the past few decades along with the wellness industry.
“The popular belief is that a supplement is going to be helpful for promoting health,” says Fang Fang Zhang, a professor at Tufts University&rs...
Source: TIME: Health - April 28, 2022 Category: Consumer Health News Authors: Sandeep Ravindran Tags: Uncategorized Diet & Nutrition healthscienceclimate Source Type: news
Continued Monitoring Needed for Anti-VEGF Therapy in Macular Edema
TUESDAY, April 26, 2022 -- Continued monitoring and treatment with anti-vascular endothelial growth factor therapy as needed maintains long-term visual benefit in patients with macular edema due to central retinal or hemiretinal vein occlusion,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 26, 2022 Category: Pharmaceuticals Source Type: news
Evidence-based screening to optimize the yield of positive ophthalmologic examinations in children evaluated for suspected child abuse - Su M, Taylor K, Stoutin J, Shaver C, Recko M.
PURPOSE: To determine nonocular findings associated with significant retinal hemorrhage on dilated fundus examination in cases of suspected child abuse. METHODS: This was a retrospective chart review from May 2014 to August 2021 at a level-1 trauma... (Source: SafetyLit)
Source: SafetyLit - April 25, 2022 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Vision improvement is long-lasting with treatment for blinding blood vessel condition
NIH-funded study finds many patients with retinal vein occlusion have vision benefits, but require long-term monitoring and treatment. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - April 21, 2022 Category: American Health Source Type: news
Erectile Dysfunction Drugs Linked With Risk for Eye Problems Erectile Dysfunction Drugs Linked With Risk for Eye Problems
Popular drugs prescribed for erectile dysfunction may entail an increased risk for adverse eye conditions such as retinal detachment.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - April 20, 2022 Category: Urology & Nephrology Tags: Ophthalmology News Source Type: news
Nanoscope Therapeutics Appoints Pharma Industry Veteran Aaron Osborne, MBBS, as Chief Medical Officer and Chief Development Officer
DALLAS, April 18, 2022 -- (Healthcare Sales & Marketing Network) -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal diseases, today announced Aaron Osborne, MBBS, was appointed Chief Medical Office... Biopharmaceuticals, Personnel Nanoscope Therapeutics, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 18, 2022 Category: Pharmaceuticals Source Type: news
Rate of Retinal Vein Occlusions Up After COVID-19 Infection
FRIDAY, April 15, 2022 -- The risk for retinal vein occlusion (RVO) may be increased in the six months following COVID-19 infection, according to a study published online April 14 in JAMA Ophthalmology.
Bobeck S. Modjtahedi, M.D., from the Southern... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 15, 2022 Category: Pharmaceuticals Source Type: news
Vision-Threatening Retinal Condition Linked to COVID-19
(MedPage Today) -- COVID-19 infection may be boosting the numbers of a rare ocular condition in which vision is threatened when veins in the retina are blocked, eye specialists in Southern California report.
Risk of retinal vein occlusion was... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - April 14, 2022 Category: Infectious Diseases Source Type: news
A biomechanical assessment of shaken baby syndrome: what about the spine? - Davison MA, Button KD, Benzel EC, Weaver BT, Rundell SA.
BACKGROUND: Shaken Baby Syndrome occurs following inertial loading of the pediatric head resulting in retinal hemorrhaging, subdural hematoma, and encephalopathy. However, the anatomically vulnerable cervical spine receives little attention. Automotive saf... (Source: SafetyLit)
Source: SafetyLit - April 5, 2022 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Outlook Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for ONS-5010 as a Treatment for Wet AMD
ISELIN, N.J., March 31, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 31, 2022 Category: Drugs & Pharmacology Source Type: news
Cell & Gene Therapy: High stakes and high hopes for healthcare
Revolutionary cell and gene therapies (CGT) delivering breakthrough treatments have begun to disrupt healthcare. The companies building these next-generation pharma technologies are introducing radically new operating models, influencing industry development and attracting large-scale media and investor attention. However, while growing rapidly, CGT is expected to see around just $34 billion of sales in 2030, up from $4.4 billion in 2020 compared to the global industry figure of £1.27 trillion in 2020. Although there are hundreds of CGT treatments in the pipeline, the challenges have so far kept the approved treatments ...
Source: EyeForPharma - March 29, 2022 Category: Pharmaceuticals Authors: Pamela Whitby Source Type: news
When Should I Be Worried About a Retinal Migraine? How Long Does It Last?
Title: When Should I Be Worried About a Retinal Migraine? How Long Does It Last?Category: Diseases and ConditionsCreated: 3/29/2022 12:00:00 AMLast Editorial Review: 3/29/2022 12:00:00 AM (Source: MedicineNet Migraine General)
Source: MedicineNet Migraine General - March 29, 2022 Category: Neurology Source Type: news
Johnson & Johnson Consumer Health Unveils New Skin Health Research at 2022 American Academy of Dermatology Meeting
SKILLMAN, N.J., March 25, 2022 – Johnson & Johnson Consumer Inc. will present new research highlighting important advances in the understanding and treatment of skin at the 2022 American Academy of Dermatology (AAD) Meeting, taking place March 25-29 in Boston, MA. A total of 11 posters ranging from the effects of oat against environmental and anti-inflammatory triggers to a vitamin C serum with clinical benefits across diverse skin types will be presented at this year’s meeting. “At Johnson & Johnson Consumer Health, we take pride in the breadth of our scientific solutions for healthier skin, which continue t...
Source: Johnson and Johnson - March 25, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
vitamin A
Title: vitamin ACategory: MedicationsCreated: 3/24/2022 12:00:00 AMLast Editorial Review: 3/24/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - March 24, 2022 Category: Dermatology Source Type: news
